[Food and Drug Administration (FDA)](https://www.fda.gov)

Estimated August 2025 (forecasted)

Expected 2 awards; details on award size not specified (cooperative agreement).

Supports research into novel approaches for advancing therapeutic development in ultra-rare cancers.

Forecasted opportunity; dates and funding details subject to change.

--- ## Description This funding opportunity, offered by the Food and Drug Administration (FDA), aims to support research exploring innovative methods to facilitate the development of therapies for ultra-rare cancers. The program seeks to advance novel strategies that can address challenges unique to therapeutic development in these understudied and difficult-to-treat cancer populations. --- ## Due Dates - Estimated application due date: August 2025 (forecasted) *All dates are projected based on the annual cycle; check the program page for updates.* --- ## Funding Amount - Expected number of awards: 2 cooperative agreements - Award size and total program funding: Not yet specified (details to be provided in the official announcement) - Cost sharing/matching: Not required --- ## Eligibility Eligible applicants include: - State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Native American tribal organizations (other than Federally recognized tribal governments) - Public housing authorities/Indian housing authorities - Nonprofits with or without 501(c)(3) status (other than institutions of higher education) - Private institutions of higher education - For-profit organizations (including small businesses) --- ## Application Process - This is a forecasted opportunity; the official application package and detailed instructions will be released closer to the estimated due date. - Interested applicants should monitor the [Grants.gov listing](https://www.grants.gov/search-results-detail/360223) for updates and the official Notice of Funding Opportunity. --- ## Additional Information - Funding instrument: Cooperative agreement (indicating substantial involvement by FDA program staff). - Program activity categories: Food and Nutrition, Consumer Protection, Agriculture. - Assistance Listing: 93.103 — Food and Drug Administration Research. - The opportunity is currently in forecast status; all details are subject to change. --- ## External Links - [FDA Funder Page](https://www.fda.gov) - [Grants.gov Opportunity Listing](https://www.grants.gov/search-results-detail/360223) --- ## Contact Information | Name | Role | Email | Phone | |------------------|-----------------------------|-----------------------------------------|--------------| | Patrick Johnson | Grants Management Specialist | [patrick.johnson@fda.hhs.gov](mailto:patrick.johnson@fda.hhs.gov) | 301-796-0154 |

Novel approaches to support therapeutic development in ultra-rare cancers

Sign in to see full grant listing